Similarly, the nearby gene MADD for the RAPSN locus has various cancers, neoplasms and glucose-related phenotypes as associated diseases in Open Targets Genetics; and is a recognized T2D gene, which when knocked out in mice, show impaired glucose tolerance, hyperglycemia and abnormal pancreatic beta cell morphology. This evidence concerns the gene MADD and type 2 diabetes mellitus.